As opioid overdose deaths rose during the COVID-19 pandemic, people seeking treatment for opioid addiction had to wait nearly twice as long to begin methadone treatment in the United States than in Canada, a new Yale study has shown.
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.
UC San Diego researchers and their colleagues at the Icahn School of Medicine at Mount Sinai in New York have discovered that spontaneous impulses of dopamine, the neurological messenger known as the brain's "feel good" chemical, occur in the brain of mice. The study found that mice can willfully manipulate these random dopamine pulses for reward.
A new study published online today in the Journal of the National Cancer Institute reports that one third of the most popular cancer treatment articles on social media contain misinformation.
Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective.
Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.
As a newborn mammal opens its eyes for the first time, it can already make visual sense of the world around it. But how does this happen before they have experienced sight?
DeepMind is partnering with EMBL to make the most complete and accurate database yet of the predicted human protein structures freely and openly available to the scientific community The AlphaFold Protein Structure Database will enable research that advances understanding of these building blocks of life, accelerating research across a variety of fields. AlphaFold's impact is already being realised by early partners researching neglected diseases, studying antibiotic resistance, and recycling single-use plastics.
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed.
Participation in elite adult rugby may be associated with changes in brain structure.